The Vanguard Group 13D and 13G filings for IDEXX Laboratories, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-12 3:48 pm Unchanged |
2024-09-30 | 13G | IDEXX Laboratories, Inc. IDXX |
The Vanguard Group | 9,703,237 11.780% |
0 (Unchanged) |
Filing |
| 2024-11-04 11:47 am Purchase |
2024-09-30 | 13G | IDEXX Laboratories, Inc. IDXX |
The Vanguard Group | 9,703,237 11.780% |
1,325,570 (+15.82%) |
Filing |
| 2024-02-13 5:06 pm Purchase |
2023-12-29 | 13G | IDEXX Laboratories, Inc. IDXX |
The Vanguard Group | 8,377,667 10.090% |
45,970 (+0.55%) |
Filing |
| 2023-12-08 4:16 pm Purchase |
2023-11-30 | 13G | IDEXX Laboratories, Inc. IDXX |
The Vanguard Group | 8,331,697 10.030% |
199,218 (+2.45%) |
Filing |
| 2023-02-09 11:22 am Purchase |
2022-12-30 | 13G | IDEXX Laboratories, Inc. IDXX |
The Vanguard Group | 8,132,479 9.820% |
209,013 (+2.64%) |
Filing |
| 2022-02-10 08:17 am Sale |
2021-12-31 | 13G | IDEXX Laboratories, Inc. IDXX |
The Vanguard Group | 7,923,466 9.340% |
-1,181,793 (-12.98%) |
Filing |
| 2021-02-10 11:03 am Sale |
2020-12-31 | 13G | IDEXX Laboratories, Inc. IDXX |
The Vanguard Group | 9,105,259 10.670% |
-344,559 (-3.65%) |
Filing |